Aimei Health (AFJK) Fundamental Analysis: Revenue, Earnings & Valuation

4.04 / 10

Netural

Fundamental rating is Neutral (4.0/10). Inventory turnover (47.95) and fixed‑asset turnover (7,896) are strong, while current‑asset ratio (0.055) and Asset‑MV (-0.485) are weak. Diluted EPS fell 35.8%, limiting upside.

Analysis Checks(7/10)

Inventory turnover ratio

Value47.95

Score2/3

Weight11.47%

1M Return1.58%

Gross profit margin (%)

Value36.92

Score2/3

Weight11.72%

1M Return1.58%

Quick ratio

Value2.20

Score2/3

Weight11.46%

1M Return1.58%

Rate of return on total assets (%)

Value-0.98

Score2/3

Weight11.60%

1M Return1.61%

Fixed assets turnover ratio

Value7895.57

Score3/3

Weight20.68%

1M Return2.82%

Annualized return on total assets (%)

Value-1.31

Score2/3

Weight11.60%

1M Return1.61%

Diluted earnings per share (YoY growth rate %)

Value-35.76

Score0/3

Weight6.58%

1M Return0.93%

Asset-MV

Value-0.49

Score0/3

Weight-8.28%

1M Return-1.25%

Current assets / Total assets (%)

Value0.05

Score1/3

Weight11.21%

1M Return1.50%

Current ratio

Value0.01

Score2/3

Weight11.94%

1M Return1.60%

Is AFJK undervalued or overvalued?

AFJK scores 4.04/10 on fundamentals and holds a Fair valuation at present. Backed by its 1.68% ROE, 0.00% net margin, 110.70 P/E ratio, 3.70 P/B ratio, and -78.46% earnings growth, these metrics solidify its Netural investment rating.